• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种具有更高稳定性和抗 HIV-1 活性的工程化 HIV-1 gp41 三聚体卷曲螺旋:开发抗 HIV 微生态制剂的意义。

An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides.

机构信息

School of Life Sciences, Tsinghua University, Key Laboratory for Protein Sciences of MOE, Beijing 100084, China.

出版信息

J Antimicrob Chemother. 2013 Nov;68(11):2533-44. doi: 10.1093/jac/dkt230. Epub 2013 Jun 21.

DOI:10.1093/jac/dkt230
PMID:23794600
Abstract

OBJECTIVES

We previously constructed a trimeric coiled coil, N28Fd, based on the N-heptad repeat (NHR) sequence of HIV-1 gp41, as a promising HIV-1 entry inhibitor. Here, we attempted to engineer a stabilized trimeric coiled coil, ccN28Fd, by adding interchain disulphide bonds at the N terminus of N28Fd to improve its biophysical properties and anti-HIV-1 efficacy.

METHODS

Molecular biology techniques were applied to engineer ccN28Fd. Circular dichroism and sedimentation velocity analysis were used to determine its secondary structure and thermostability and polymeric states, respectively. The anti-HIV-1 activity was assessed by p24 or luciferase expression. Its cytotoxicity was evaluated by XTT assay.

RESULTS

At low pH, ccN28Fd and N28Fd were in trimeric and monomeric conformation, respectively. ccN28Fd showed higher thermostability and much stronger antiviral activity against HIV-1 IIIB (X4) and Bal (R5) strains than N28Fd. ccN28Fd was effective in inhibiting infection by a broad spectrum of primary HIV-1 isolates and enfuvirtide-resistant strains and blocking cell-to-cell HIV-1 transmission. A combination of ccN28Fd with tenofovir, a nucleoside reverse transcriptase inhibitor-based microbicide, exhibited potent synergistic anti-HIV-1 activity. ccN28Fd was highly resistant to digestion by proteinase K at pH 7.2 and pepsin at pH 1.5, and its anti-HIV-1 activity was not significantly affected by the presence of hydroxyethyl cellulose gel, seminal fluid or vaginal fluid simulant. It possessed no significant in vitro cytotoxicity.

CONCLUSIONS

The engineered ccN28Fd maintains high stability in a low pH environment and exhibits potent and broad anti-HIV-1 activity, suggesting good potential for development as an effective and safe vaginal microbicide to prevent HIV sexual transmission.

摘要

目的

我们先前基于 HIV-1 gp41 的 N-七肽重复(NHR)序列构建了三聚体卷曲螺旋 N28Fd,作为有前途的 HIV-1 进入抑制剂。在此,我们试图通过在 N28Fd 的 N 端添加链间二硫键来构建稳定的三聚体卷曲螺旋 ccN28Fd,以改善其物理化学性质和抗 HIV-1 功效。

方法

应用分子生物学技术构建 ccN28Fd。使用圆二色性和沉降速度分析分别确定其二级结构和热稳定性以及聚合状态。通过 p24 或荧光素酶表达评估抗 HIV-1 活性。通过 XTT 测定评估其细胞毒性。

结果

在低 pH 值下,ccN28Fd 和 N28Fd 分别处于三聚体和单体构象。ccN28Fd 表现出更高的热稳定性和对 HIV-1 IIIB(X4)和 Bal(R5)株更强的抗病毒活性。ccN28Fd 有效抑制广泛的原发性 HIV-1 分离株和恩夫韦肽耐药株的感染,并阻断细胞间 HIV-1 的传播。ccN28Fd 与核苷逆转录酶抑制剂为基础的杀微生物剂替诺福韦联合使用具有协同抗 HIV-1 活性。ccN28Fd 在 pH 值为 7.2 时对蛋白酶 K 和 pH 值为 1.5 时对胃蛋白酶具有高度抗性,其抗 HIV-1 活性不受羟乙基纤维素凝胶、精液或阴道液模拟物的存在显著影响。它没有明显的体外细胞毒性。

结论

工程化的 ccN28Fd 在低 pH 值环境下保持高度稳定,表现出强大而广泛的抗 HIV-1 活性,表明其作为有效和安全的阴道杀微生物剂预防 HIV 性传播具有良好的开发潜力。

相似文献

1
An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides.一种具有更高稳定性和抗 HIV-1 活性的工程化 HIV-1 gp41 三聚体卷曲螺旋:开发抗 HIV 微生态制剂的意义。
J Antimicrob Chemother. 2013 Nov;68(11):2533-44. doi: 10.1093/jac/dkt230. Epub 2013 Jun 21.
2
Novel recombinant engineered gp41 N-terminal heptad repeat trimers and their potential as anti-HIV-1 therapeutics or microbicides.新型重组工程 gp41 N 端七肽重复三聚体及其作为抗 HIV-1 治疗药物或杀微生物剂的潜力。
J Biol Chem. 2010 Aug 13;285(33):25506-15. doi: 10.1074/jbc.M110.101170. Epub 2010 Jun 10.
3
Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.HIV gp41 N区域卷曲螺旋的共价稳定作用产生了极其强效且广谱的病毒感染抑制剂。
Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12903-8. doi: 10.1073/pnas.0502449102. Epub 2005 Aug 29.
4
Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.一种细菌表达的HIV-1 gp41融合抑制剂的蛋白质设计
Biochemistry. 2007 Apr 10;46(14):4360-9. doi: 10.1021/bi7001289. Epub 2007 Mar 20.
5
Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.人工肽与胆固醇和口袋特异性小分子缀合,可有效抑制实验室适应和原发性 HIV-1 分离株以及恩夫韦肽耐药 HIV-1 株的感染。
J Antimicrob Chemother. 2014 Jun;69(6):1537-45. doi: 10.1093/jac/dku010. Epub 2014 Feb 4.
6
Antiviral properties of two trimeric recombinant gp41 proteins.两种三聚体重组gp41蛋白的抗病毒特性
Retrovirology. 2006 Mar 3;3:16. doi: 10.1186/1742-4690-3-16.
7
Suitable fusion of N-terminal heptad repeats to achieve covalently stabilized potent N-peptide inhibitors of HIV-1 infection.合适的 N 端七肽重复融合以实现共价稳定的强效 N 肽抑制剂抗 HIV-1 感染。
Bioorg Med Chem. 2020 Feb 15;28(4):115214. doi: 10.1016/j.bmc.2019.115214. Epub 2019 Nov 25.
8
Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.源自HIV-1、HIV-2和SIV不同毒株gp41 C末端七肽重复序列的C34肽对HIV-1和SIV包膜介导的细胞融合的差异抑制作用
J Med Chem. 2005 Apr 21;48(8):3036-44. doi: 10.1021/jm049026h.
9
Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti-HIV-1 drugs.具有作为抗HIV-1药物潜力的gp41 N端七肽重复区域的单链蛋白质模拟物。
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18207-12. doi: 10.1073/pnas.1413592112. Epub 2014 Dec 8.
10
An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor.人免疫缺陷病毒(HIV-1)包膜糖蛋白前体中存在gp41七肽重复序列1区域卷曲螺旋的另一种构象。
Virology. 2005 Jul 20;338(1):133-43. doi: 10.1016/j.virol.2005.05.001.

引用本文的文献

1
Inactivation of cell-free HIV-1 by designing potent peptides based on mutations in the CD4 binding site.基于 CD4 结合位点突变设计强效肽以灭活无细胞 HIV-1。
Med Biol Eng Comput. 2024 Feb;62(2):423-436. doi: 10.1007/s11517-023-02950-8. Epub 2023 Oct 27.
2
Peptide-Based Dual HIV and Coronavirus Entry Inhibitors.基于肽的双重HIV和冠状病毒进入抑制剂
Adv Exp Med Biol. 2022;1366:87-100. doi: 10.1007/978-981-16-8702-0_6.
3
Conformational Stabilization of Gp41-Mimetic Miniproteins Opens Up New Ways of Inhibiting HIV-1 Fusion.
构象稳定的 Gp41 模拟型小蛋白为抑制 HIV-1 融合开辟了新途径。
Int J Mol Sci. 2022 Mar 3;23(5):2794. doi: 10.3390/ijms23052794.
4
A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.一种高效且稳定的泛冠状病毒融合抑制剂,作为COVID-19和其他冠状病毒疾病的预防性和治疗性候选药物。
Acta Pharm Sin B. 2022 Apr;12(4):1652-1661. doi: 10.1016/j.apsb.2021.07.026. Epub 2021 Aug 2.
5
and Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine.并且同源卷曲螺旋候选物作为一种潜在的交叉保护疫苗。
Front Immunol. 2020 Oct 21;11:574330. doi: 10.3389/fimmu.2020.574330. eCollection 2020.
6
IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodies.IgG Fc 结合基序偶联的 HIV-1 融合抑制剂表现出增强的效力和体内半衰期:与广谱中和抗体联合应用的潜力。
PLoS Pathog. 2019 Dec 5;15(12):e1008082. doi: 10.1371/journal.ppat.1008082. eCollection 2019 Dec.
7
A Novel CXCR4 Targeting Protein SDF-1/54 as an HIV-1 Entry Inhibitor.一种新型的靶向CXCR4的蛋白质SDF-1/54作为HIV-1进入抑制剂
Viruses. 2019 Sep 18;11(9):874. doi: 10.3390/v11090874.
8
Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41.基于蛋白质和肽的 HIV 进入抑制剂的开发,针对 gp120 或 gp41。
Viruses. 2019 Aug 1;11(8):705. doi: 10.3390/v11080705.
9
design of isopeptide bond-tethered triple-stranded coiled coils with exceptional resistance to unfolding and proteolysis: implication for developing antiviral therapeutics.具有卓越抗解折叠和抗蛋白水解能力的异肽键连接三链卷曲螺旋的设计:对开发抗病毒疗法的启示
Chem Sci. 2015 Nov 1;6(11):6505-6509. doi: 10.1039/c5sc02220g. Epub 2015 Aug 6.
10
An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications.一种用于在包膜病毒表面糖蛋白中重现N端七肽重复三聚体以用于治疗应用的有效策略。
Chem Sci. 2016 Mar 1;7(3):2145-2150. doi: 10.1039/c5sc04046a. Epub 2015 Dec 3.